Menu

Natacha TURCK

Genève 4

Electionseuropéennes 2024

RETROUVEZ GRATUITEMENTLe résultat des européennes à Annecy ainsi que le résultat des européennes en Haute-Savoie.

En résumé

Dr. Natacha Turck began her scientific career (INSERM U.682, Strasbourg, France) by studying fundamental sciences in the oncology field. She acquired skills in biochemistry, proteomics, cellular/ molecular biology and obtained in 2004, a PhD degree in Life Sciences. She moved to Switzerland in 2005 in order to join the Faculty of Medicine in Geneva, as post-doctoral researcher. In this new context, she learnt translational research specifically applied to brain damage diseases. Her objectives were to discover and validate proteins as new biomarkers for helping decision on diagnosis, prognosis, treatment, etc…in the context of stroke. Now, she has a senior position in the Faculty of Medicine in Geneva and works as senior translational Researcher, always in the brain damage context but extended to other diseases such as SAH, traumatic brain injury (TBI), multiple sclerosis (MS/SEP), Sleeping sickness, Parkinson…. More recently, she has decided to develop a new research axis on lacrimal fluid as source of biomarkers (group leader of the OPTICS group).
During all her career, she interacts daily with multi-disciplinary people (chemists, bio-IT specialists, statisticians, physicians,…) and manage up to 12 persons (from trainees to senior scientists). She has a substantial experience in cerebrovascular diseases, biomarkers (discovery, validation process, IVD) and clinical fields (clinical studies, intend-of-use ,statistics). Beside sciences, she has also institutional and teaching responsibilities in the Faculty of Medicine but also internationally.

-Tears as source of biomarkers for ocular and systemic diseases.
-Technical skills: biochemistry, proteomics, cellular / molecular biology.
-biomarkers strategies : from discovery to clinics. Include statistics.
-Clinical field: Stroke, SAH, traumatic brain injury (TBI), multiple sclerosis (MS/SEP), Sleeping sickness, Parkinson, Ocular diseases
-Teaching, institutional and international responsabilities

Mes compétences :
proteomics
Research
Statistics
Enseignement universitaire
Coordination de projets
Recherche de financement
Direction de projet
Biologie
Biochimie
Recherche
Recherche médicale clinique

Entreprises

  • Université De Genève - Senior scientist, translational project manager, biomarker specialist

    Genève 4 2015 - maintenant Since 2015, I work as independent group leader on the exploration of human tears as a promising new source for discovering biomarkers for ocular but also systemic diseases. In this context, I develop and manage several translational projects from the discovery phase using proteomics strategies up to the clinical phase (validation). Furthermore, these projects involve multi disciplinary interactions, good knowledge in clinical procedures, statistics and requirement of the IVD markets (collaboration with private compagnies). In parallel, I assume national and international responsabilities (executive editor of Journal of Proteomics, active member of EuPA association).

    Exploring human tears as source of biomarkers for ocular and systemic diseases.
    * Innovative projects, proof-of-concept
    * From the discovery to the clinics
    * Omics field
    * Bioinformatics and statistical skills
    * Clinical studies (GCP, GLP)
    * Multidisciplinary project manager
    * National and international collaborations inlcuding private compagnies
    * National and international responsabilities: Ex Ed of Journal of Proteomics, Associated Editor of Disease Biomarker journal

  • Université De Genève - Senior scientist, Biomarker specialist

    Genève 4 2005 - 2015 During one decade, I worked as senior project manager on translation projects dedicated to brain diseases (Stroke, SAH, TBI, multiple sclerosis, sleeping sickness...) (Post-doctorate and Maitre- Assistante position in Geneva University, Switzerland) . Whatever the project, my final goals were to discover new biomarkers using proteomics strategies and to verify/validate them on independent cohorts. To assure the clinical success of my projects, I interacted daily with clinical teams.

    Discovery and validation of brain damage biomarkers (stroke, multiple sclerosis, trauma brain injury, sleeping sickness, parkinson)
    * Proteomics, ELISA/Bioplex, Protoarrays
    * Statistical Analysis of data
    * Clinical studies
    * Contact with pharmaceutical companies
    * Supervisor of technicians, trainees and doctorants
    * Other responsabilities:
    -President of ACERM (Association des Collaborateurs de l'Enseignement de la Recherche à la faculté de Médecine de Genève)
    -Member of the R2 Committee (commission recherche et relève de la Faculté dde Médecine)
    -Teaching: Courses and Lab workshops in Bioinformatic and Proteomics Master and Neurosciences Master (Geneva University, Switzerland) in French and English. Courses in 2nd year of Medical School (cardiovascular option) and Electrophoretics TD in 1st year of Medical School
    - Ex. Ed of Journal of Proteomics and Ass. Ed of Disease Biomarker Journal

Formations

Réseau

Annuaire des membres :